The large open-market sale by the Counterpart Health CEO, unaccompanied by a 10b5-1 plan, is the most notable signal. Monitor for any upcoming earnings pre-announcement or operational update from Clover Health, particularly regarding Counterpart Health's performance. The absence of any insider buying alongside this cluster reinforces the bearish read.
Price Chart
Executive Summary
Four Clover Health insiders, including the CEO of Counterpart Health and the CEO of Medicare Advantage, sold a total of $1.60M in open-market sales over a 7-day window. The largest sale ($1.42M) by the Counterpart Health CEO represents a significant insider disposition, while the other sales are modest in absolute dollar terms. This cluster of selling, particularly the large sale by a key subsidiary CEO, signals potential concern about near-term prospects.
Key Financial Metrics
Key Facts
- Four insiders sold shares in open-market transactions totaling $1.60M between September 8-15, 2026.
- Wai Conrad (CEO, Counterpart Health) sold 300,000 shares for $1.42M at $4.72/share on September 15.
- Reynoso Jamie L. (CEO, Medicare Advantage) sold 9,273 shares for $44,325 at $4.78/share on September 15.
- Soares Karen (Chief Legal Officer) sold 6,800 shares for $32,504 at $4.78/share on September 15.
- OLDAKOWSKI JOSEPH FRANK (VP of Finance and Controller) sold 20,000 shares for $103,200 at $5.16/share on September 14.
- No 10b5-1 plan indication was provided for any of the sales.
Financial Impact
Total insider selling of $1.60M, with $1.42M from the Counterpart Health CEO alone. Relative to a market cap of approximately $326M (based on ~68M shares at ~$4.80), this represents ~0.5% of market cap, which is at the upper end of the 'modest' range.
Risk Factors
- Insider selling may reflect personal liquidity needs rather than negative outlook, but the cluster nature and lack of 10b5-1 plans increase the signal.
- The Counterpart Health CEO's large sale could indicate concerns about that subsidiary's growth or reimbursement trajectory.
- Clover Health's stock has been volatile historically, and insider selling may not always predict near-term price moves.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CLOV-1789620781995 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 7d ago | Insider Cluster | $4.78 $4.73 | ▲ +1.05% | ▼ −0.13% | $4.63 (+3.14%) |
Oct 19, 2026 8d ago | 144 | $4.80 $4.78 | ▼ −0.42% | ▼ −0.94% | $4.63 (−3.54%) |
Oct 19, 2026 8d ago | Insider Cluster | $4.80 $4.78 | ▼ −0.42% | ▼ −0.94% | $4.63 (−3.54%) |
Oct 8, 2026 19d ago | 8-K | $4.79 $4.78 | ▼ −0.21% | ▼ −0.15% | $4.63 (−3.34%) |
Oct 7, 2026 20d ago | 144 | $4.58 $4.79 | ▲ +4.59% | ▲ +3.99% | $4.63 (+1.09%) |
Oct 5, 2026 22d ago | Insider Cluster | $4.60 $4.56 | ▲ +0.87% | ▲ +0.63% | $4.63 (−0.65%) |
Oct 1, 2026 26d ago | 3 | $4.38 $4.68 | ▲ +6.85% | ▲ +6.17% | $4.63 (+5.71%) |
Sep 24, 2026 4w ago | 8-K | $4.49 $4.33 | ▼ −3.56% | ▼ −2.82% | $4.63 (+3.12%) |
Sep 18, 2026 5w ago | Insider Cluster | $4.54 $4.67 | ▼ −2.86% | ▼ −2.88% | $4.63 (−1.98%) |
Sep 17, 2026 5w ago | Insider Cluster | $4.46 $4.54 | ▼ −1.79% | ▼ −0.24% | $4.63 (−3.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers